Marc S. Ernstoff

Publications

3 shown

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Julie R. Brahmer , Christina Lacchetti , Bryan J. Schneider +26 more

Purpose To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint i...

2018 Journal of Clinical Oncology 3484 citations

Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

Michael A. Postow , Jason Chesney , Anna C. Pavlick +18 more

The objective-response rate and the progression-free survival among patients with advanced melanoma who had not previously received treatment were significantly greater with niv...

2015 New England Journal of Medicine 2716 citations

Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma

Paul B. Chapman , Lawrence H. Einhorn , Michael L. Meyers +9 more

PURPOSE: Several single-institution phase II trials have reported that the Dartmouth regimen (dacarbazine, cisplatin, carmustine, and tamoxifen) can induce major tumor responses...

1999 Journal of Clinical Oncology 756 citations

Researcher Info

h-index: 3
Publications: 3
Citations: 6,956
Institution: American Society of Clinical Oncology

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-8132-7069

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.

Publications

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma

Frequent Co-Authors

Julie R. Brahmer

Christina Lacchetti

Bryan J. Schneider

Michael B. Atkins

Kelly Brassil

Jeffrey M. Caterino

Researcher Info

External Links

Identifiers

Impact Metrics